Marijke joined the Cobiores team from Oxurion (former ThromboGenics) as of beginning 2019. After obtaining a Bachelor degree in Pharmaceutical Biotechnology at KHLeuven, she started working at the VRC in the group of Professor Janssens and gained a broad cardiovascular and molecular background.
Moving to ThromboGenics provided her the opportunity to contribute into the startup of the Cytotoxic Drug Department with a focus on the development of innovative oncology treatments. Later on the company’s Ophthalmology group solicited her experience for the in vivo team projects into the field of “back of the eye disease”.
Within CoBioRes, Marijke reinforces the Cancer Therapeutics’ research team and will apply her knowledge to contribute into the expansion of the Oncology lab and research facilities.